Clinical benefits of bone targeted agents in early breast cancer

Coleman, R. orcid.org/0000-0002-4275-1043 (2019) Clinical benefits of bone targeted agents in early breast cancer. The Breast, 48 (Supplement 1). S92-S96. ISSN 0960-9776

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Elsevier.
Keywords: Adjuvant therapy; bisphosphonates; denosumab; bone metastases
Dates:
  • Published (online): 12 December 2019
  • Published: November 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 17 Apr 2020 15:02
Last Modified: 07 May 2020 12:10
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/s0960-9776(19)31133-6
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics